Artificial intelligence in histopathology: enhancing cancer research and clinical oncology

Research output: Contribution to journalReview articleContributedpeer-review

Contributors

  • Artem Shmatko - , German Cancer Research Center (DKFZ), EMBL European Bioinformatics Institute (EBI) (Author)
  • Narmin Ghaffari Laleh - , RWTH Aachen University (Author)
  • Moritz Gerstung - , German Cancer Research Center (DKFZ), EMBL European Bioinformatics Institute (EBI) (Author)
  • Jakob Nikolas Kather - , Else Kröner Fresenius Center for Digital Health, RWTH Aachen University, Heidelberg University , University of Leeds (Author)

Abstract

Artificial intelligence (AI) methods have multiplied our capabilities to extract quantitative information from digital histopathology images. AI is expected to reduce workload for human experts, improve the objectivity and consistency of pathology reports, and have a clinical impact by extracting hidden information from routinely available data. Here, we describe how AI can be used to predict cancer outcome, treatment response, genetic alterations and gene expression from digitized histopathology slides. We summarize the underlying technologies and emerging approaches, noting limitations, including the need for data sharing and standards. Finally, we discuss the broader implications of AI in cancer research and oncology.

Details

Original languageEnglish
Pages (from-to)1026-1038
Number of pages13
JournalNature cancer
Volume3
Issue number9
Publication statusPublished - Sept 2022
Peer-reviewedYes

External IDs

PubMed 36138135

Keywords

Sustainable Development Goals

ASJC Scopus subject areas

Library keywords